Login or Sign Up
15:56 May 26
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd. Corporate Actions
Eris Lifesciences Ltd.
Industry Pharmaceuticals
15:56 May 26
Quality
64/100
High Financial Strength
Valuation
39/100
Mid Valuation
Technical
39/100
Technically Neutral
Strength
8
Weakness
4
Opportunity
1
Threats
1
0.00 %
Dividend Yield
18.86K
Market Cap (Cr)
RSI
53.92 %
Promoter Holding
19.79 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 29-May-2026 | Dividend | 7.21/share@721.00% | 29-May-2026 | 721.00 | Interim |
| 13-Feb-2025 | Dividend | 7.35/share@735.00% | 13-Feb-2025 | 735.00 | Interim |
| 11-Aug-2022 | Dividend | 7.35/share@735.00% | 16-Aug-2022 | 735.00 | Interim |
| 05-Aug-2021 | Dividend | 6.01/share@601.00% | 06-Aug-2021 | 601.00 | Interim |
| 13-Aug-2020 | Dividend | 5.50/share@550.00% | 14-Aug-2020 | 550.00 | Interim |
| 19-Mar-2020 | Dividend | 2.87/share@287.00% | 20-Mar-2020 | 287.00 | Interim |
| 12-Jul-2019 | Tender Offer | Ratio | - | - | - |
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully